Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis ; volume:9 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (3.4.2019), 1-11, 12.2019
- Creator
-
Moik, Florian
Riedl, Jakob M.
Winder, Thomas
Terbuch, Angelika
Rossmann, Christopher H.
Szkandera, Joanna
Bauernhofer, Thomas
Kasparek, Anne-Katrin
Schaberl-Moser, Renate
Reicher, Andreas
Prinz, Felix
Pichler, Martin
Stöger, Herbert
Stotz, Michael
Gerger, Armin
Posch, Florian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-42069-1
- URN
-
urn:nbn:de:101:1-2019041921165389938283
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moik, Florian
- Riedl, Jakob M.
- Winder, Thomas
- Terbuch, Angelika
- Rossmann, Christopher H.
- Szkandera, Joanna
- Bauernhofer, Thomas
- Kasparek, Anne-Katrin
- Schaberl-Moser, Renate
- Reicher, Andreas
- Prinz, Felix
- Pichler, Martin
- Stöger, Herbert
- Stotz, Michael
- Gerger, Armin
- Posch, Florian
- SpringerLink (Online service)
Other Objects (12)
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach
Biliary tract large cell neuroendocrine carcinoma: current evidence
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach
Biliary tract large cell neuroendocrine carcinoma: current evidence
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
Biliary tract radiology
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Imaging of Benign Biliary Tract Disease
Biliary Tract Obstruction by Unusual Parasites
Biliary Tract Obstruction Due to Sarcoidosis
Efficacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers: data from a randomised phase II study
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
Biliary tract and gallbladder cancer : a multidisciplinary approach